Skip to main content

Table 4 The dynamics of changes in carbohydrate metabolism observed during the course of treatment in patients with nonalcoholic steatohepatitis and concomitant obesity, mean ± SD

From: The efficacy of L-carnitine in patients with nonalcoholic steatohepatitis and concomitant obesity

Parameter

Group

T0 of treatment

T1 after the start of treatment

T2 after the start of treatment

Fasting glucose, mmol/L

1

5.77 ± 0.13*

5.63 ± 0.14*

5.25 ± 0.08**

2

5.81 ± 0.15*

5.08 ± 0.09**/***

4.96 ± 0.05**/***

2-hour postprandial glucose, mmol/L

1

9.01 ± 0.32*

8.57 ± 0.24*

7.80 ± 0.14*/**

2

9.05 ± 0.24*

7.96 ± 0.16*

7.31 ± 0.10**/***

Insulin, µU/mL

1

23.10 ± 2.41*

18.86 ± 2.33*

16.2 ± 1.32*

2

23.15 ± 2.35*

15.17 ± 1.48*/**

10.02 ± 0.55**/***

HOMA-IR

1

3.02 ± 0.12*

2.47 ± 0.18 *

2.10 ± 0.15*/**

2

3.03 ± 0.14*

1.82 ± 0.08 */**/***

1.29 ± 0.07**/***

  1. Note: ** – the difference is significant compared to the pretreatment value (P < 0.05); *** – the difference is significant compared to the posttreatment value obtained for group 1 subjects (P < 0.05)